MAPT and Alzheimer disease: In combination, our results suggest a mechanistic model in which PR protects mice from worsening AD pathology and preserves cognition via inhibition of brain mTORC1 activity, which reduces AD pathology—especially tau phosphorylation—by increasing autophagy.